Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Hysterectomy, hysteroscopy & ablation · New York | Hysterectomy, hysteroscopy & ablation · Pennsylvania | |
|---|---|---|
| Surgeons, 2024 | 75 | 52 |
| Medicare fee-for-service cases | 6,108 | 4,366 |
| Growth since 2019 (Medicare FFS) | −0.3%/yr | −2%/yr |
| Forecast cases (Medicare FFS) | 6,960 in 2030 | 4,620 in 2030 |
| Forecast growth | +2.2%/yr to 2030 | +0.9%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.7 | 3.5 |
| Medicare Advantage share | 57% | 58% |
| Out of hospital | 30% (+6 pts since 2019) | 10% (−7 pts since 2019) |
| Cases per surgeon | 81 | 84 |
| Top 10 surgeons' share | 26% | 37% |
| Surgeons growing | 4 | 3 |
| New since the base year | 8 | 6 |
| Likely to stop billing it | 32 by 2026 | 27 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $874 | $744 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.